Yuviwel
NDC 73362-202, Navepegritide, kit, from Ascendis Pharma Endocrinology, Inc..
- Product NDC
- 73362-202
- Status
- Listed
- Labeler
- Ascendis Pharma Endocrinology, Inc.
- Dosage form
- KIT
- Route
- —
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA219164
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/73362-202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
None listed.
| Package NDC | NDC-11 | Package |
|---|---|---|
| 73362-202-01 | 73362020201 | 4 BOX in 1 CARTON (73362-202-01) / 1 KIT in 1 BOX (73362-202-02) * 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (73362-206-01) * 1 SOLUTION in 1 SYRINGE, GLASS (73362-801-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/e01c1197-338f-414c-b804-808e129ebc8c
Use it
Look up 73362-202 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/73362-202 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 73362-202. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.